Abstract
Plant molecular farming is the production of recombinant pharmaceutical and nonpharmaceutical proteins of commercial importance utilizing plants as bioreactors. Research and development on plant-derived recombinant proteins have gained momentum in recent years. Advantages of employing plants as bioreactors for recombinant protein generation are many including low cost of production, easier scale-up, cost-effective storage, and absence of animal pathogens in protein preparations. This article reviews the various technologies developed for employing plants as bioreactors, different plant systems being used as expression host, and limitations and research advances to overcome these limitations. An overview of different plant-derived products whether currently in market or are in different stages of development, including phases of clinical trials, is described. Special emphasis has been given on banana being used as an expression host, advantages and limitations of using banana in plant molecular farming, and different approaches which can be utilized to overcome those limitations have been described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ananiev EV, Wu C, Chamberlin MA, Svitashev S, Schwartz C, Gordon-Kamm W et al (2009) Artificial chromosome formation in maize (Zea mays L.). Chromosoma 118:157–177
Barta A, Sommengruber K, Thompson D, Hartmuth K, Matzke MA, Matzke AJM (1986) The expression of a napoline synthase human growth hormone chimeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol 6:347–357
Basaran P, Rodríguez-Cerezo E (2008) Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol 28:153–172
Bendich AJ (1987) Why do chloroplast and mitochondria contain so many copies of their genome? Bioessays 6:279–282
Bhat SR, Srinivasan S (2002) Molecular and genetic analyses of transgenic plants: considerations and approaches. Plant Sci 163:673–681
Bhatla SC, Kaushik V, Yadav MK (2010) Use of oil bodies and oleosins in recombinant protein production and other biotechnological applications. Biotechnol Adv 28:293–300
Biemelt S, Sonnewald U (2005) Molecular farming in plants. Nature encyclopedia of life sciences. Nature Publishing Group, London. doi:10.1038/npg.els.0003365. http://www.els.net/
Breyer D, Goossens M, Herman P, Sneyers M (2009) Biosafety considerations associated with molecular farming in genetically modified plants. J Med Plants Res 3:825–838
Canizares MC, Nicholson L, Lomonossoff GP (2005) Use of viral vectors for vaccine production in plants. Immunol Cell Biol 83:263–270
Caroca R, Howell KA, Hasse C, Ruf S, Bock R (2013) Design of chimeric expression elements that confer high-level gene activity in chromoplasts. Plant J 73:368–379
Chan HT, Daniell H (2015) Plant-made oral vaccines against human infectious diseases-are we there yet? Plant Biotechnol J 13:70
Chen M, Liu M, Wang Z, Song J, Qi Q, Wang PG (2005) Modification of plant N-glycans processing: the future of producing therapeutic proteins in transgenic plants. Med Res Rev 25:343–360
Christensen AH, Quail PH (1996) Ubiquitin promoter-based vectors for high-level expression of selectable and/or screenable marker genes in monocotyledonous plants. Transgenic Res 5:213–218
Clendennen SK, Lopez-Gomez R, Gomez-Lim M et al (1998) The abundant 31-kilodalton banana pulp protein is homologous to class III acidic chitinases. Phytochemistry 47:613–619
Commandeur U, Twyman RM, Fischer R (2003) The biosafety of molecular farming in plants. AgBiotechNet 5:ABN 110
Corrado G, Karali M (2009) Inducible gene expression systems and plant biotechnology. Biotechnol Adv 27:733–743
Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, Peele CG et al (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24:1591–1597
Cramer CL, Weissenborn DL, Oishi KK et al (1996) High level production of enzymatically active human lysosomal proteins in transgenic plants. In: Owen MRL, Pen J (eds) Transgenic plants: a production system for industrial and pharmaceutical protein. Wiley, Chichester, pp 299–310
Daniell H, Streatfield SJ, Wycoff K (2001a) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6:219–226
Daniell H, Lee SB, Panchal T, Wiebe PO (2001b) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 311:1001–1009
Daniell H, Khan MS, Allison L (2002) Milestones in chloroplast genetic engineering: an environmentally friendly era in biotechnology. Trends Plant Sci 7:84–91
De Jaeger G, Scheffer S, Jacobs A, Zambre M, Zobell O, Goossens A et al (2002) Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nat Biotechnol 20:1265–1268
De Paepe A, De Buck S, Hoorelbeke K, Nolf J, Peck I, Depicker (2009) A high frequency of single copy T-DNA transformants by floral dip in CRE-expressing Arabidopsis plants. Plant J 59:517–527
Decker EL, Reski R (2004) The moss bioreactor. Curr Opin Plant Biol 7:166–170
Decker EL, Reski R (2008) Current achievements in the production of complex biopharmaceuticals with moss bioreactors. Bioprocess Biosyst Eng 31:3–9
Delaney DE (2002) Choice of crop species and development of transgenic product lines. In: Hood EE, Howard JA (eds) Plants as factories for protein production. Kluwer, Dordrecht, pp 139–158
Doran PM (2000) Foreign protein production in plant tissue cultures. Curr Opin Biotechnol 11:199–204
Drake PMW, Barbi T, Sexton A, McGowan E, Stadlmann J, Navarre C, Paul MJ, Ma JKC (2009) Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. FASEB J 23:3581–3589
Elliott S, Lorenzini T, Asher S et al (2003) Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 21:414–421
Faye L, Gomord V (2010) Success stories in molecular farming—a brief overview. Plant Biotechnol J 8:525–528
Faye L, Boulaflous A, Benchabane M, Gomord V, Michaud D (2005) Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming. Vaccine 23:1770–1778
Fischer R, Emans NJ, Twyman RM, Schillberg S (2004) Molecular farming in plants: technology platforms. In: Goodman RB (ed) Encyclopedia of plant and crop science. Marcel Dekker, New York, pp 753–756
Floss DM, Sack M, Arcalis E, Stadlmann J, Quendler H, Rademacher T et al (2009) Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol J 7:899–913
Franconi R, Demurtas OC, Massa S (2010) Plant-derived vaccines and other therapeutics produced in contained systems. Expert Rev Vaccin 9:877–892
Franklin SE, Mayfield SP (2005) Recent developments in the production of human therapeutic proteins in eukaryotic algae. Expert Opin Biol Ther 5:225–235
Frigerio L, de Virgilio M, Prada A, Faoro F, Vitale A (1998) Sorting of phaseolin to the vacuole is saturable and requires a short C-terminal peptide. Plant Cell 10:1031–1042
Ganapathi TR, Higgs NS, Balint-Kurti PJ, Arntzen CJ, May GD, Van Eck JM (2001) Agrobacterium mediated transformation of embryogenic cell suspensions of the banana cultivar Rasthali (AAB). Plant Cell Rep 20:157–162
Gasdaska JR, Spencer D, Dickey L (2003) Advantages of therapeutic protein production in the aquatic plant Lemna. BioProcess J 2:49–56
Gaume A, Komarnytsky S, Borisjuk N, Raskin I (2003) Rhizosecretion of recombinant proteins from plant hairy roots. Plant Cell Rep 21:1188–1193
Ghosh A, Shekhawat UKS, Ganapathi TR, Bapat VA (2012) Analysis of banana fruit-specific promoters using transient expression in embryogenic cells of banana cultivar Robusta (AAA Group). J Plant Biochem Biot 21:189–197
Giritch A, Marillonnet S, Engler C, van Eldik G, Botterman J, Klimyuk V et al (2006) Rapid high yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc Natl Acad Sci U S A 103:14701–14706
Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection—a new platform for expressing recombinant vaccines in plants. Vaccine 23:2042–2048
Gomord V, Sourrouille C, Fitchette AC et al (2004) Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge. Plant Biotechnol J 2:83–100
Guillon S, Trémouillaux-Guiller J, Kumar Pati P, Rideau M, Gantet P (2006) Hairy root research: recent scenario and exciting prospects. Curr Opin Plant Biol 9:341–346
Hamamoto H, Sugiyama Y, Nakagawa N et al (1993) A new tobacco mosaic virus vector and its use for the systemic production of angiotensin – 1 converting enzyme inhibitor in transgenic tobacco and tomato. Biotechnology 11:930–932
He Z, Jiang XL, Qi Y, Di QL (2008) Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression. Genetica 133:207–214
Higo K, Saito Y, Higo H (1993) Expression of a chemically synthesized gene for human epidermal growth factor under the control of cauliflower mosaic virus 35S promoter in transgenic tobacco. Biosci Biotechnol Biochem 57:1477–1481
Hohe A, Decker E, Gorr G, Schween G, Reski R (2002) Tight control of growth and cell differentiation in photoautotrophically growing moss (Physcomitrella patens) bioreactor cultures. Plant Cell Rep 20:1135–1140
Hood EE, Witcher DR, Maddock S, Meyer T, Baszczynski C, Bailey M et al (1997) Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol Breed 3:291–306
Horn ME, Woodard SL, Howard JA (2004) Plant molecular farming: systems and products. Plant Cell Rep 22:711–720
Huang Z, Santi L, LePore K et al (2006) Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 24:2506–2513
Jost W, Link S, Horstmann V et al (2005) Isolation and characterization of three moss-derived betatubulin promoters suitable for recombinant expression. Curr Genet 47:111–120
Kaiser J (2008) Is the drought over for pharming? Science 320:473–475
Kang JS, Frank J, Kang CH, Kajiura H, Vikram M, Ueda A (2008) Salt tolerance of Arabidopsis thaliana requires maturation of N-glycosylated proteins in the Golgi apparatus. Proc Natl Acad Sci U S A 105:5933–5938
Kapila J, De Rycke R, van Montagu M et al (1997) An Agrobacterium mediated transient expression system for intact leaves. Plant Sci 122:101–108
Key S, Ma JKC, Drake PMW (2008) Genetically modified plants and human health. J R Soc Med 101:290–298
Kim TG, Baek M, Lee EK, Kwon T-H, Yang M-S (2008) Expression of human growth hormone in transgenic rice cell suspension culture. Plant Cell Rep 27:885–891
Koide Y, Hirano H, Matsuoka K, Nakamura K (1997) The N-terminal propeptide of the precursor to sporamin acts as a vacuole-targeting signal even at the C terminus of the mature part in tobacco cells. Plant Physiol 114:863–870
Koprivova A, Stemmer C, Altmann F, Hoffmann A, Kopriva S, Gorr G et al (2004) Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J 2:517–523
Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P (2003) Structural analysis of human IgGFc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 325:979–989
Kumar SGB, Ganapathi TR, Bapat VA (2004) Edible vaccines: current status and future prospects. Physiol Mol Biol Plants 10:37–47
Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA (2005) Expression of hepatitis B surface antigen in transgenic banana plants. Planta 222:484–493
Kumar S, Hahn FM, Baidoo E, Kahlon TS, Wood DF, McMahan CM, Cornish K, Keasling JD, Daniell H, Whalen MC (2012) Remodeling the isoprenoid pathway in tobacco by expressing the cytoplasmic mevalonate pathway in chloroplasts. Metab Eng 14:19–28
Lamphear BJ, Streatfield SJ, Jilka JM, Brooks CA, Barker DK, Turner DD et al (2002) Delivery of subunit vaccines in maize seed. J Control Release 85:169–180
LaVallie ER, McCoy JM (1995) Gene fusion expression systems in Escherichia coli. Curr Opin Biotechnol 6:501–506
Lienard D, Sourrouille C, Gomord V, Faye L (2007) Pharming and transgenic plants. Biotechnol Ann Rev 13:115–147
Lu J, Sivamani E, Azhakanandam K, Samadder P, Li X, Qu R (2008) Gene expression enhancement mediated by the 5′ UTR intron of the rice rubi3 gene varied remarkably among tissues in transgenic rice plants. Mol Genet Genomics 279:563–572
Lutcke HA, Chow KC, Mickel FS, Moss KA, Kern HF, Scheele GA (1987) Selection of AUG initiation codons differs in plants and animals. EMBO J 6:43–48
Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805
Magnuson NS, Linzmaier PM, Reeves R et al (1998) Secretion of biologically active human interleukin- 2 and interleukin-4 from genetically modified tobacco cells in suspension culture. Protein Exp Purif 13:45–52
Mainieri D, Rossi M, Archinti M, Bellucci M, De Marchis F, Vavassori S et al (2004) Zeolin. A new recombinant storage protein constructed using maize gamma-zein and bean phaseolin. Plant Physiol 136:3447–3456
Mason HS, Warzecha H, Mor T, Arntzen CJ (2002) Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 8:324–329
Matsumoto S, Ikura K, Ueda M et al (1995) Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Plant Mol Biol 27:1163–1172
May GD, Kipp PB (1997) Gene promoter sequence from banana. Patent No. WO 9738106-A 1, Zeneca LTD (GB)
Mayfield SP, Franklin SE, Lerner RA (2003) Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci U S A 100:438–442
McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F et al (2008) Plant produced idiotype vaccines for the treatment of non-Hodgkin’s lymphoma: safety and immunogenicity in a phase I clinical study. Proc Natl Acad Sci U S A 105:10131–10136
Mishra S, Yadav DK, Tuli R (2006) Ubiquitin fusion enhances cholera toxin B subunit expression in transgenic plants and the plant-expressed protein binds GM1 receptors more efficiently. J Biotechnol 127:95–108
Muntz K (1998) Deposition of storage proteins. Plant Mol Biol 38:77–99
Murphy DJ (1993) Structure, function and biogenesis of storage lipid bodies and oleosins in plants. Prog Lipid Res 32:247–280
Nagaya S, Kawamura K, Shinmyo A, Kato K (2010) The HSP terminator of Arabidopsis thaliana increases gene expression in plant cells. Plant Cell Physiol 51:328–332
Nara Y, Kurata H, Seki M, Taira K (2000) Glucocorticoid-induced expression of a foreign gene by the GVG system in transformed tobacco BY-2 cells. Biochem Eng J 6:185–191
Ni M, Cui D, Einstein J, Narasimhulu S, Vergara CE, Gelvin SB (1995) Strength and tissue specificity of chimeric promoters derived from the octopine and mannopine synthase genes. Plant J 7:661–676
Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M et al (2007) Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A 104:10986–10991
Obembe OO, Popoola JO, Leelavathi S, Reddy SV (2011) Advances in plant molecular farming. Biotechnol Adv 29:210–222
Padidam M (2003) Chemically regulated gene expression in plants. Curr Opin Plant Biol 6:169–177
Palacpac NQ, Yoshida S, Sakai H et al (1999) Stable expression of human 1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc Natl Acad Sci U S A 96:4692–4697
Pelham HR (1990) The retention signal for soluble proteins of the endoplasmic reticulum. Trends Biochem Sci 15:483–486
Peumans WJ, Proost P, Swennen RL et al (2002) The abundant class III chitinase homolog in young developing banana fruits behaves as a transient vegetative storage protein and most probably serves as an important supply of amino acids for the synthesis of ripening-associated proteins. Plant Physiol 130:1063–1072
Porta C, Lomonossoff GP (2002) Viruses as vectors for the expression of foreign sequences in plants. Biotechnol Genet Eng Rev 19:245–291
Ramessar K, Sabalza M, Capell T, Christou P (2008) Maize plants: an ideal production platform for effective and safe molecular pharming. Plant Sci 174:409–419
Rosales-Mendoza S, Soria-Guerra RE, Moreno-Fierros L, Alpuche-Solís ÁG, Martínez-González L, Korban SS (2010) Expression of an immunogenic F1-V fusion protein in lettuce as a plant-based vaccine against plague. Planta 232:409–416
Ruhlman T, Verma D, Samson N, Daniell H (2010) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol 152:2088–2104
Rybicki EP (2010) Plant-made vaccines for humans and animals. Plant Biotechnol J 8:620–637
Salmon V, Legrand D, Slomianny MC et al (1998) Production of human lactoferrin in transgenic tobacco plants. Prot Expr Purif 13:127–135
Santi L, Giritch A, Roy CJ et al (2006) Protection conferred by recombinant Yersinia pestis antigen produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci U S A 103:861–866
Schaefer DG (2002) A new moss genetics: targeted mutagenesis in Physcomitrella patens. Annu Rev Plant Biol 53:477–501
Schillberg S, Twyman RM, Fischer R (2005) Opportunities for recombinant antigen and antibody expression in transgenic plants—technology assessment. Vaccine 23:1764–1769
Schillberg S, Raven N, Fischer R, Twyman RM, Schiermeyer A (2013) Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures. Curr Pharm Design 19:5531–5542
Schunmann PHD, Surin B, Waterhouse PM (2003) A suite of novel promoters and terminators for plant biotechnology. II. The pPLEX series for use in monocots. Funct Plant Biol 30:453–460
Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G et al (2007) Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system. Plant Biotechnol J 5:579–590
Sharma AK, Sharma MK (2009) Plants as bioreactors: recent developments and emerging opportunities. Biotechnol Adv 27:811–832
Sharma MK, Singh NK, Jani D, Sisodia R, Thungapathra M, Gautam JK et al (2008) Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to choleratoxin B subunit in transgenic tomato (Solanum lycopersicum). Plant Cell Rep 27:307–318
Sijmons PC, Dekker BMM, Schrammeijer B et al (1990) Production of correctly processed human serum albumin in transgenic plants. Biotechnology 8:217–221
Smith ML, Keegan ME, Mason HS, Schuler ML (2002) Factors important in the extraction, stability and in vitro assembly of the hepatitis B surface antigen derived from recombinant plant systems. Biotechnol Prog 18:538–550
Smith ML, Richter L, Arntzen CJ, Schuler ML, Mason HS (2003) Structural characterization of plant derived hepatitis B surface antigen employed in oral immunization studies. Vaccine 21:4011–4021
Sourrouille C, Marquet-Blouin E, D’Aoust MA, Kiefer-Meyer M-C, Seveno M, Pagny-Salehabadi S et al (2008) Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol J 6:702–721
Sparrow PA, Irwin JA, Dale PJ, Twyman RM, Ma JK (2007) Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals. Transgenic Res 16:147–161
Spiker S, Thompson WF (1996) Nuclear matrix attachment regions and transgene expression in plants. Plant Physiol 110:15–21
Staub JM, Garcia B, Graves J et al (2000) High yield production of a human therapeutic protein in tobacco chloroplasts. Nat Biotechnol 18:333–338
Stoger E, Sack M, Fischer R, Christou P (2002) Plantibodies: applications, advantages and bottlenecks. Curr Opin Biotechnol 13:161–166
Stoger E, Ma JKC, Fischer R, Christou P (2005) Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 16:167–173
Streatfield SJ, Howard JA (2003) Plant-based vaccines. Int J Parasitol 33:479–493
Tremblay R, Wang D, Jevnikar AM, Ma S (2010) Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol Adv 28:214–221
Twyman RM, Schillberg S, Fischer R (2005) Transgenic plants in the biopharmaceutical market. Expert Opin Emerg Drugs 10:185–218
Valenzuela P, Medina A, Rutter W, Ammerer G, Hall B (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347–350
Vaquero C, Sack M, Chandler J et al (1999) Transient expression of a tumor specific single chain fragment and a chimeric antibody in tobacco leaves. Proc Natl Acad Sci U S A 96:11128–11133
Vézina L-P, Faye L, Lerouge P, D’Aoust M-A, Marquet-Blouin E, Burel C et al (2009) Transient coexpression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnol J 7:442–455
Voinnet O, Rivas S, Mestre P, Baulcombe D (2003) An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus. Plant J 33:949–956
Walmsley AM, Arntzen CJ (2003) Plant cell factories and mucosal vaccines. Curr Opin Biotechnol 14:145–150
Wenderoth I, von Schaewen A (2000) Isolation and characterization of plant N-acetyl glucosaminyltransferase I (GntI) cDNA sequences. Functional analyses in the Arabidopsis cgl mutant and in antisense plants. Plant Physiol 123:1097–1108
Wilde CD, Peeters K, Jacobs A, Peck I, Depicker A (2002) Expression of antibodies and Fab fragments in transgenic potato plants: a case study for bulk production in crop plants. Mol Breed 9:271–282
Woodleif WG, Chaplin JF, Campbell CR et al (1981) Effect of variety and harvest treatments on protein yield of close grown tobacco. Tob Sci 25:83–86
Yang D, Wu L, Hwang YS, Chen L, Huang N (2001) Expression of the REB transcriptional activator in rice grains improves the yield of recombinant proteins whose genes are controlled by a Reb-responsive promoter. Proc Natl Acad Sci U S A 98:11438–11443
Yano M, Hirai T, Kato K, Hiwasa-Tanase K, Fukuda N, Ezura H (2010) Tomato is a suitable material for producing recombinant miraculin protein in genetically stable manner. Plant Sci 178:469–473
Yao J, Weng Y, Dickey A, Wang KY (2015) Plants as factories for human pharmaceuticals: applications and challenges. Int J Mol Sci 16:28549–28565
Acknowledgment
Authors thank Dr. SP Kale, Head, Nuclear Agriculture and Biotechnology Division, BARC, for his constant encouragement. VAB thanks Indian National Science Academy, New Delhi for Senior Scientist Fellowship.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Tak, H., Negi, S., Ganapathi, T.R., Bapat, V.A. (2016). Molecular Farming: Prospects and Limitation. In: Mohandas, S., Ravishankar, K. (eds) Banana: Genomics and Transgenic Approaches for Genetic Improvement. Springer, Singapore. https://doi.org/10.1007/978-981-10-1585-4_18
Download citation
DOI: https://doi.org/10.1007/978-981-10-1585-4_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1583-0
Online ISBN: 978-981-10-1585-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)